FS Development Corp II Cl A (FSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FSII | ABOS | CGEN | ||
| Company | FS Development Corp II Cl A | Acumen Pharmaceuticals Inc | Compugen Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.05 | 3.37 | 2.19 | ||
| High | 10.16 | 3.46 | 2.32 | ||
| Low | 9.69 | 3.18 | 2.19 | ||
| Latest | 9.80 | 3.32 | 2.30 | ||
| Change | -0.20 | -0.04 | +0.06 | ||
| % Change | -2.00% | -1.19% | +2.68% | ||
| Volume | 289,100 | 225,537 | 330,098 | ||
| 20-Day Average Volume | 227,795 | 304,601 | 313,315 | ||
| Previous Close | 10.00 | 3.36 | 2.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.86 | 2.91 | 1.90 | ||
| 20-Day Raw Stochastic | 2.99% | 84.99% | 97.79% | ||
| 20-Day Relative Strength | 38.90 | 65.95 | 63.19 | ||
| Weighted Alpha | -13.88 | +160.95 | +47.96 | ||
| Today's Opinion | 8% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 8% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 72% Buy | 100% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.89% since 12/16/21 | +0.30% since 03/04/26 | +7.24% since 03/04/26 | ||
| Low | 9.64 on 12/21/21 | 3.05 on 03/09/26 | 2.00 on 03/06/26 | ||
| High | 10.86 on 12/21/21 | 3.49 on 03/10/26 | 2.31 on 03/11/26 | ||
| 1-Month | |||||
| %Chg | -30.10% since 11/23/21 | +29.69% since 02/11/26 | +34.21% since 02/11/26 | ||
| Low | 9.64 on 12/21/21 | 2.34 on 02/12/26 | 1.63 on 02/12/26 | ||
| High | 15.00 on 12/01/21 | 3.49 on 03/10/26 | 2.31 on 03/11/26 | ||
| 3-Month | |||||
| %Chg | -1.90% since 09/23/21 | +69.39% since 12/11/25 | +43.44% since 12/11/25 | ||
| Low | 9.64 on 12/21/21 | 1.67 on 01/12/26 | 1.43 on 12/30/25 | ||
| High | 15.05 on 11/19/21 | 3.49 on 03/10/26 | 2.38 on 01/16/26 | ||
| 6-Month | |||||
| %Chg | -0.81% since 06/23/21 | +138.85% since 09/11/25 | +63.93% since 09/11/25 | ||
| Low | 9.64 on 12/21/21 | 1.21 on 09/16/25 | 1.29 on 09/22/25 | ||
| High | 15.05 on 11/19/21 | 3.49 on 03/10/26 | 2.38 on 01/16/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 203,125 | 203,525 | 199,898 | ||
| Shares Outstanding, K | 20,727 | 60,573 | 89,240 | ||
| Annual Sales | 0 | 0 | 72,760,000 | ||
| Annual Net Income | 0 | -102,330,000 | 35,340,000 | ||
| Last Quarter Sales | 0 | 0 | 67,330,000 | ||
| Last Quarter Net Income | -1,220,000 | -26,450,000 | 56,850,000 | ||
| 60-Month Beta | N/A | 0.21 | 2.90 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/12/21 | -0.44 on 11/12/25 | -0.07 on 11/10/25 | ||
| Latest Earnings Date | 01/01/70 | 03/26/26 | 05/18/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 5.81 | ||